Literature DB >> 20004413

Calculating Cornell voltage from nonstandard chest electrode recording site in the Reasons for Geographic And Racial Differences in Stroke study.

Elsayed Z Soliman1, George Howard, Ronald J Prineas, Leslie A McClure, Virginia J Howard.   

Abstract

BACKGROUND: To minimize participants' burden and the need for disrobing, a 7-lead electrocardiogram (ECG) recording using a single mid-sternal chest lead was recorded at the initial stages of The REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Electrocardiogram-detected left ventricular hypertrophy (ECG-LVH) by Cornell voltage (RaVL + S-wave amplitude in V(3) [SV(3)]) cannot be assessed from this method because of the absence of V(3). We examined the possibility that the S-wave amplitude in the mid-sternal lead (SV) could be used as a surrogate for SV(3).
METHODS: The REGARDS study is a US national study where 7-lead ECGs were performed in 8,330 (29%) participants and standard 12-lead EGCs were performed in 20 811 (71%). Cornell voltage was calculated as the sum of aVL amplitude + SV (in the 7-lead group) or SV(3) (in the 12-lead group). Logistic regression analysis was used to examine and compare the magnitude of the association between the LVH risk factors with ECG-LVH in both groups, and Cox proportional hazards analysis was used to examine and compare the hazard ratios of overall mortality and cardiovascular mortality associated with ECG-LVH in both groups.
RESULTS: Regardless of the Cornell voltage calculation method, ECG-LVH was significantly associated with LVH risk factors; and with the exception of sex, there was no evidence of a difference in the magnitude of the association. ECG-LVH from both approaches were significantly and similarly associated with both all-cause and cardiovascular mortality.
CONCLUSION: ECG-LVH by Cornell voltage calculated from a 7-lead ECG (using SV in the formula) has demographic and clinical associations that are similar to that calculated from a standard 12-lead ECG (using SV(3)). In epidemiologic studies recording 7-lead ECG, SV could be used as an alternative to SV(3) in the Cornell voltage formula. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20004413      PMCID: PMC2856789          DOI: 10.1016/j.jelectrocard.2009.10.002

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  14 in total

1.  Minimal lead sets for reconstruction of 12-lead electrocardiograms.

Authors:  S P Nelwan; J A Kors; S H Meij
Journal:  J Electrocardiol       Date:  2000       Impact factor: 1.438

2.  Simultaneous comparison of three derived 12-lead ECGs with standard ECG at rest and during percutaneous coronary occlusion.

Authors:  Stephan P Nelwan; Suzanne W Crater; Simon H Meij; Teus B van Dam; Jan A Kors; Maarten L Simoons; Mitchell W Krucoff
Journal:  J Electrocardiol       Date:  2004       Impact factor: 1.438

Review 3.  AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology.

Authors:  E William Hancock; Barbara J Deal; David M Mirvis; Peter Okin; Paul Kligfield; Leonard S Gettes; James J Bailey; Rory Childers; Anton Gorgels; Mark Josephson; Jan A Kors; Peter Macfarlane; Jay W Mason; Olle Pahlm; Pentti M Rautaharju; Borys Surawicz; Gerard van Herpen; Galen S Wagner; Hein Wellens
Journal:  Circulation       Date:  2009-02-19       Impact factor: 29.690

4.  The aV limb leads in the diagnosis of ventricular strain.

Authors:  J A SCHACK; R H ROSENMAN; L N KATZ
Journal:  Am Heart J       Date:  1950-11       Impact factor: 4.749

5.  Prognostic value of electrocardiographic criteria for left ventricular hypertrophy.

Authors:  Bill P Hsieh; Michael X Pham; Victor F Froelicher
Journal:  Am Heart J       Date:  2005-07       Impact factor: 4.749

6.  A point-score system for the ECG diagnosis of left ventricular hypertrophy.

Authors:  D W Romhilt; E H Estes
Journal:  Am Heart J       Date:  1968-06       Impact factor: 4.749

7.  Clinical-physiological correlations in the development of hypertensive heart disease.

Authors:  E D Frohlich; R C Tarazi; H P Dustan
Journal:  Circulation       Date:  1971-09       Impact factor: 29.690

8.  How many electrodes and where? A "poldermodel" for electrocardiography.

Authors:  Jan A Kors; Gerard van Herpen
Journal:  J Electrocardiol       Date:  2002       Impact factor: 1.438

9.  Comparison of a new reduced lead set ECG with the standard ECG for diagnosing cardiac arrhythmias and myocardial ischemia.

Authors:  Barbara J Drew; Michele M Pelter; Donald E Brodnick; Anil V Yadav; Debbie Dempel; Mary G Adams
Journal:  J Electrocardiol       Date:  2002       Impact factor: 1.438

10.  Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria.

Authors:  P N Casale; R B Devereux; P Kligfield; R R Eisenberg; D H Miller; B S Chaudhary; M C Phillips
Journal:  J Am Coll Cardiol       Date:  1985-09       Impact factor: 24.094

View more
  21 in total

1.  Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Usman Baber; Virginia J Howard; Jonathan L Halperin; Elsayed Z Soliman; Xiao Zhang; William McClellan; David G Warnock; Paul Muntner
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-11-13

2.  Vascular risk factors and cognitive impairment in a stroke-free cohort.

Authors:  F W Unverzagt; L A McClure; V G Wadley; N S Jenny; R C Go; M Cushman; B M Kissela; B J Kelley; R Kennedy; C S Moy; V Howard; G Howard
Journal:  Neurology       Date:  2011-11-08       Impact factor: 9.910

3.  Revised Framingham Stroke Risk Profile to Reflect Temporal Trends.

Authors:  Carole Dufouil; Alexa Beiser; Leslie A McLure; Philip A Wolf; Christophe Tzourio; Virginia J Howard; Andrew J Westwood; Jayandra J Himali; Lisa Sullivan; Hugo J Aparicio; Margaret Kelly-Hayes; Karen Ritchie; Carlos S Kase; Aleksandra Pikula; Jose R Romero; Ralph B D'Agostino; Cécilia Samieri; Ramachandran S Vasan; Genevieve Chêne; George Howard; Sudha Seshadri
Journal:  Circulation       Date:  2017-02-03       Impact factor: 29.690

4.  N-terminal pro-B-type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohort.

Authors:  Mary Cushman; Suzanne E Judd; Virginia J Howard; Brett Kissela; Orlando M Gutiérrez; Nancy S Jenny; Ali Ahmed; Evan L Thacker; Neil A Zakai
Journal:  Stroke       Date:  2014-04-22       Impact factor: 7.914

Review 5.  Coronary heart disease risk factors and outcomes in the twenty-first century: findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Hemal Bhatt; Monika Safford; Stephen Glasser
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

6.  Fibroblast growth factor 23 and risk of incident stroke in community-living adults.

Authors:  Bhupesh Panwar; Nancy S Jenny; Virginia J Howard; Virginia G Wadley; Paul Muntner; Brett M Kissela; Suzanne E Judd; Orlando M Gutiérrez
Journal:  Stroke       Date:  2015-01-06       Impact factor: 7.914

7.  Fine particulate air pollution and premature ventricular contractions: The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study.

Authors:  Wesley T O'Neal; Elsayed Z Soliman; Jimmy T Efird; Virginia J Howard; George Howard; Leslie A McClure
Journal:  Environ Res       Date:  2017-01-03       Impact factor: 6.498

8.  Verbal fluency in a national sample: Telephone administration methods.

Authors:  Janice C Marceaux; Michelle A Prosje; Leslie A McClure; Bhumika Kana; Michael Crowe; Brett Kissela; Jennifer Manly; George Howard; Joyce W Tam; Frederick W Unverzagt; Virginia G Wadley
Journal:  Int J Geriatr Psychiatry       Date:  2019-01-18       Impact factor: 3.485

9.  Association of Fibroblast Growth Factor 23 With Risk of Incident Coronary Heart Disease in Community-Living Adults.

Authors:  Bhupesh Panwar; Suzanne E Judd; Virginia G Wadley; Nancy S Jenny; Virginia J Howard; Monika M Safford; Orlando M Gutiérrez
Journal:  JAMA Cardiol       Date:  2018-04-01       Impact factor: 14.676

10.  Association of stroke risk biomarkers with stroke symptoms: the Reasons for Geographic and Racial Differences in Stroke cohort.

Authors:  K K Landry; K S Alexander; N A Zakai; S E Judd; D O Kleindorfer; V J Howard; G Howard; M Cushman
Journal:  J Thromb Haemost       Date:  2016-12-09       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.